Sun, 28th Feb 2021 22:40
Feb 28 (Reuters) - AstraZeneca Plc has sold its
stake in Moderna Inc for more than $1 billion after the
American biotechnology company's shares soared on the back of
its coronavirus vaccine breakthrough, The Times reported.
The report added that it was not clear when and over what
period AstraZeneca sold its full holding in Moderna.
(Reporting by Maria Ponnezhath in Bengaluru; editing by
Jonathan Oatis)
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.
AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...
(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...
AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...
Astrazeneca (AZN)